Nanoparticle-Based Drug Delivery

Nanoparticle-based drug delivery involves engineering particles at the scale of billionths of a meter to carry therapeutic compounds through the body and release them at specific sites, most often tumors. Because particles at this scale interact with biological tissue differently than bulk materials do, researchers can exploit effects like the enhanced permeability and retention phenomenon—where leaky tumor vasculature allows nanocarriers to accumulate preferentially in cancerous tissue—to concentrate drugs where they are needed while reducing damage to healthy cells. Surface engineering, which involves attaching molecules such as antibodies or polymers to a particle's outer layer, is a central area of development, as is the use of magnetic nanoparticles that can be guided or activated by external fields. Active questions include how to make targeting precise enough to work reliably across the biological variability of real patients, and how to design particles that clear the body safely after delivering their payload.

Works

89,652

Total citations

2,852,238

Keywords

NanocarriersDrug DeliveryNanoparticlesCancer TherapySurface EngineeringMagnetic Nanoparticles